EP3520816
ANTI-GCC ANTIBODY MOLECULES AND RELATED COMPOSITIONS AND METHODS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
22.10.2010EP published:
31.8.2022EP application number:
19153014.6
EPO information:
European Patent Register
Max expiry date:
21.10.2030
Title in English:
ANTI-GCC ANTIBODY MOLECULES AND RELATED COMPOSITIONS AND METHODSLanguage of the patent:
English
Timeline
Today
22.10.2010EP application
31.8.2022EP Publication
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1, Doshomachi 4-chome, Chuo-ku,, Osaka-shi, Osaka, JP
Name:
Amgen British ColumbiaAddress:
7990 Enterprise Street, Burnaby, BC V5A 1V7, CA
Inventor
Name:
NAM, Samuel, S.Address:
Haverhill, MA 01832, US
Name:
GREENFIELD, Edward, A.Address:
Stoughton, MA 02072, US
Name:
BABCOOK, JohnAddress:
Vancouver, BC V6R 2R2, CA
Name:
O'KEEFE, TheresaAddress:
Waltham, MA 02453, US
Name:
QIN, ShixinAddress:
Lexington, MA 02421, US
Priority
Number:
25447409 PDate:
23.10.2009Country:
US
Classification
Categories:
C07K 16/30, A61K 39/395, C07K 16/40, A61P 35/00, A61K 47/68